Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler, Susan B. MD 1; Liu, Danni MSPH 2; Glassman, Adam R. MS 2; Blodi, Barbara A. MD 3; Castellarin, Alessandro A. MD 4; Jampol, Lee M. MD 5; Kaufman, Paul L. MD 6; Melia, Michele ScM 2; Singh, Harinderjit MD 7; Wells, John A. MD 8
[Article] JAMA Ophthalmology. 135(6):558-568, June 2017.

(Format: HTML, PDF)